Here, by using large independent patient cohorts, we identified an eight-lncRNA signature with the ability to predict the BCR of patients with PCa and demonstrated that the lncRNA signature could be used as an independent prognostic factor and improve risk stratification of current prognostic models. The gene discussed is BCR; the disease is posterior cortical atrophy.